SCHEMBL22952986

SCHEMBL22952986

Oc1ccc2c(c1O)Cc1cc(O)c(O)c3c1C2CNC3

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
HTR2A P28223 1/20 0.38
MAPK1 P28482 2/20 0.35
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
THPO P40225 1/20 0.35
HSD17B10 Q99714 1/20 0.35
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
PMP22 Q01453 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
KIF11 P52732 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16938669 0.82 HTR2A (0.60) PARP1HTR2ACYP3A4DRD2DRD1
SCHEMBL3672464 0.82 HTR2A (0.60) PARP1HTR2ACYP3A4DRD2DRD1
SCHEMBL3670524 0.82 HTR2A (0.60) PARP1HTR2ACYP3A4DRD2DRD1
SCHEMBL29383346 0.82 HTR2A (0.60) PARP1HTR2ACYP3A4DRD2DRD1
SCHEMBL22953388 0.78 HTR2A (0.43) PARP1HTR2AMAPK1CYP3A4ALOX15
SCHEMBL22952989 0.77 PARP1 (0.43) PARP1HTR2AMAPK1CYP3A4ALOX15
Bromide SCHEMBL11014029 0.76 HTR2A (0.46) PARP1HTR2AMAPK1CYP3A4NFKB1
SCHEMBL22952987 0.76 PARP1 (0.41) PARP1HTR2AMAPK1CYP3A4ALOX15
SCHEMBL22953341 0.75 PARP1 (0.43) PARP1MAPK1CYP3A4ALOX15TSHR
SCHEMBL22953390 0.75 HTR2A (0.36) PARP1HTR2ADRD2DRD1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed